Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Colombia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Colombia Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20081
20092
20102
20112
20122
20132
20161
20171
20181
20191
20232
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated5
Active, not recruiting3
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
AstraZeneca3
GlaxoSmithKline2
Pfizer2
Alnylam Pharmaceuticals1
Boehringer Ingelheim1
CSL Behring1
Eli Lilly and Company1
Esperion Therapeutics, Inc.1
Hamilton Health Sciences Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases24
Stroke8
Myocardial Infarction7
Diabetes Mellitus, Type 25
Acute Coronary Syndrome3
Atherosclerosis3
Heart Diseases3
Hyperlipidemias3
Hypertension3
Coronary Artery Disease2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.